CSNK2A2

Across TCGA pan-cancer cohorts, CSNK2A2 Mutation is linked to patient survival in 5 of 34 cancer types, making it a survival-associated CSNK2A2 data layer compared with 23 for mass-spec protein and 4 for mass-spec protein.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher CSNK2A2 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated CSNK2A2 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

LUAD, COAD, and ESCA are the cancer types where CSNK2A2 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Median	All	0.004	0.835	<.001	36	view →
COAD	OS	Median	All	0.100	0.670	<.001	21	view →
ESCA	OS	Median	All	0.211	0.700	.020	9	view →
PRAD	DFS	Median	All	0.085	0.774	<.001	6	view →
UCEC	OS	Median	All	1.000	0.866	.038	2	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

CSNK2A2–LUAD (OS)

Open the LUAD breakdown →